|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 51.45 USD | +0.39% |
|
-2.04% | +4.91% |
| 05:33pm | GSK Completes $10.6 Billion Acquisition of Nuvalent | MT |
| 05:00pm | GSK completes USD10.6 billion acquisition of Nuvalent | AN |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1,028B | |||||
| 611B | |||||
| 432B | |||||
| 323B | |||||
| 277B |
- Stock Market
- Stocks
- GSK Stock
- GSK Stock
- Charts GSK plc
- Sector Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
